Axitinib

Axitinib Related Products

Venkatasai is a leading innovator in the field of pharmaceutical reference standards, offering high-quality Reference Standards of Axitinib, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope-labeled compounds, and nitrosamines (N-NO products). Our Axitinib impurity reference standards play a vital role in pharmaceutical research, supporting product development, ANDA and DMF filings, quality control (QC), method validation, and stability studies. They are also instrumental in identifying unknown impurities and evaluating genotoxic potential. All Axitinib-related products are thoroughly characterized and supplied with comprehensive Certificates of Analysis (COA) and analytical data that comply with regulatory standards. EP/USP traceable standards can also be provided upon request. Furthermore, all supplied products undergo periodic re-testing to ensure continued quality and reliability.

Aluminum

Alaun; Alumina Fibre; Aluminium Bronze
CAT No: VS-A103050
CAS No: 7429-90-5
Mol.F.: Al
Mol.Wt.: 26.98
Status: Custom Synthesis

Axitinib

N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]sulfanyl]-benzamide?
CAT No: VS-A103000
CAS No: 319460-85-0
Mol.F.: C22H18N4OS
Mol.Wt.: 386.5
Status: Custom Synthesis

Axitinib Acid

2-[[3-[(1E)-2-(2-Pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzoic acid ;
CAT No: VS-A103002
CAS No: 319462-34-5
Mol.F.: C21H15N3O2S
Mol.Wt.: 373.4?
Status: Custom Synthesis

Axitinib Adduct -1

2-((1-((3R,4R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)-3-((E)-2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)-N-methylbenzamide
CAT No: VS-A103009
CAS No: N/A
Mol.F.: C34H38N4O11S
Mol.Wt.: 710.8
Status: Custom Synthesis

Axitinib Adduct -2

N-methyl-2-((3-((E)-2-(pyridin-2-yl)vinyl)-1-((3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl)thio)benzamide
CAT No: VS-A103010
CAS No: N/A
Mol.F.: C28H28N4O6S
Mol.Wt.: 548.6
Status: Custom Synthesis

Axitinib Amide

2-[[3-[(1E)-2-(2-Pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide
CAT No: VS-A103003
CAS No: 319462-41-4
Mol.F.: C21H16N4OS
Mol.Wt.: 372.4
Status: Custom Synthesis

Axitinib Des Iodo analog

(E)-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
CAT No: VS-A103019
CAS No: 2242852-05-5
Mol.F.: C19H19N3O
Mol.Wt.: 305.4
Status: Custom Synthesis

Axitinib Dimer Impurity 1

(Z)-N-methyl-2-((1-(1-(6-((2-(methylcarbamoyl)phenyl)thio)-1H-indazol-3-yl)-2-(pyridin-2-yl)ethyl)-3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide
CAT No: VS-A103026
CAS No: 1428728-84-0
Mol.F.: C44H36N8O2S2
Mol.Wt.: 773
Status: Custom Synthesis

Axitinib Dimer Impurity 2

2,2'-(((2,4-di(pyridin-2-yl)cyclobutane-1,3-diyl)bis(1H-indazole-3,6-diyl))bis(sulfanediyl))bis(N-methylbenzamide)
CAT No: VS-A103027
CAS No: 1428728-83-9
Mol.F.: C44H36N8O2S2
Mol.Wt.: 773
Status: Custom Synthesis

Axitinib Dimer Impurity 3

(E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
CAT No: VS-A103028
CAS No: 886230-77-9
Mol.F.: C19H18IN3O
Mol.Wt.: 431.3
Status: Custom Synthesis

Axitinib Dimer Impurity 4

(E)-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine
CAT No: VS-A103029
CAS No: 886230-76-8
Mol.F.: C19H20N4O
Mol.Wt.: 320.4
Status: Custom Synthesis

Axitinib Dimer Impurity 5

6-iodo-3-[2-(pyridin- 2yl)ethyl]-1-(tetrahydro-2H-pyran- 2-yl)-1H-indazole
CAT No: VS-A103030
CAS No: N/A
Mol.F.: C19H20IN3O
Mol.Wt.: 433.3
Status: Custom Synthesis

Axitinib Dimer Impurity 6

5-iodo-3-(2-(pyridin-2-yl)ethyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
CAT No: VS-A103031
CAS No: N/A
Mol.F.: C19H20IN3O
Mol.Wt.: 433.3
Status: Custom Synthesis

Axitinib Impurity 1

N-methyl-2-[3-[(1E)-2-(pyridinyl) ethenyl]-[N-[(5-hydroxy methyl furanyl)-hydroxy methyl]-1H-indazol-6-yl-thio]]-benzamide
CAT No: VS-A103032
CAS No: N/A
Mol.F.: C28H24N4O4S
Mol.Wt.: 512.6
Status: Custom Synthesis

Axitinib Impurity 10

3-Iodo-6-nitro-1(tetra hydro-2H-pyran-2-yl)-1H-indazole
CAT No: VS-A103040
CAS No: 886230-74-6
Mol.F.: C12H12IN3O3
Mol.Wt.: 373.2
Status: Custom Synthesis

Axitinib Impurity 11

(E)-6-((2-(methylcarbamoyl)phenyl)sulfonyl)-3-(2-(1-oxidopyridin-2-yl)vinyl)-1H-indazole 1-oxide
CAT No: VS-A103041
CAS No: N/A
Mol.F.: C22H18N4O5S
Mol.Wt.: 450.5
Status: Custom Synthesis

Axitinib Impurity 12

N-methyl-2-((6'-(2-(methylcarbamoyl)benzyl)-1H,1'H-[3,3'-biindazol]-6-yl)thio)benzamide
CAT No: VS-A103042
CAS No: N/A
Mol.F.: C31H26N6O2S
Mol.Wt.: 546.6
Status: Custom Synthesis

Axitinib Impurity 13

2-((1-((3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)-3-((E)-2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)-N-methylbenzamide
CAT No: VS-A103043
CAS No: N/A
Mol.F.: C34H38N4O11S
Mol.Wt.: 710.8
Status: Custom Synthesis

Axitinib Impurity 14

(E)-6-((2-(methylcarbamoyl)phenyl)sulfinyl)-3-(2-(1-oxidopyridin-2-yl)vinyl)-1H-indazole 1-oxide
CAT No: VS-A103044
CAS No: N/A
Mol.F.: C22H18N4O4S
Mol.Wt.: 434.5
Status: Custom Synthesis

Axitinib Impurity 15

(E)-6-((2-(methylcarbamoyl)phenyl)sulfonyl)-3-(2-(1-oxidopyridin-2-yl)vinyl)-1H-indazole 1-oxide
CAT No: VS-A103045
CAS No: N/A
Mol.F.: C22H18N4O5S
Mol.Wt.: 450.5
Status: Custom Synthesis

Axitinib Impurity 16

2-((3-Iodo-1H-indazol-6-yl)thio)-N-methylbenzamide
CAT No: VS-A103047
CAS No: 885126-34-1
Mol.F.: C15H12IN3OS
Mol.Wt.: 409.2
Status: Custom Synthesis

Axitinib Impurity 3

N-methyl-2-[3-[(1E)-2-(1-oxidopyridinyl) ethenyl]-1H-indazol-6-yl-sulfinyl]-benzamide
CAT No: VS-A103033
CAS No: 1348044-24-5
Mol.F.: C22H18N4O3S
Mol.Wt.: 418.5
Status: Custom Synthesis

Axitinib Impurity 4

N-methyl-2-[3-[(1E)-2-(1-oxidopyridinyl) ethenyl]-1-oxido-1H-indazol-6-yl-sulfinyl]-benzamide
CAT No: VS-A103034
CAS No: N/A
Mol.F.: C22H18N4O4S
Mol.Wt.: 434.5
Status: Custom Synthesis

Axitinib Impurity 5

N-methyl-2-[3-[(1E)-2-(1-oxidopyridinyl) ethenyl]-1-oxido-1H-indazol-6-yl-sulfonyl]-benzamide
CAT No: VS-A103035
CAS No: N/A
Mol.F.: C22H18N4O5S
Mol.Wt.: 450.5
Status: Custom Synthesis

Axitinib Impurity 6

N-methyl-2-[3-[(1E)-2-(1-oxidopyridinyl) ethenyl]-1H-indazol-6-yl-sulfonyl]-benzamide
CAT No: VS-A103036
CAS No: N/A
Mol.F.: C22H18N4O4S
Mol.Wt.: 434.5
Status: Custom Synthesis

Axitinib Impurity 7

(E)-N-methyl-2-((1-(2-(pyridin-2-yl)ethyl)-3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide
CAT No: VS-A103037
CAS No: 1443118-72-6
Mol.F.: C29H25N5OS
Mol.Wt.: 491.6
Status: Custom Synthesis

Axitinib Impurity 8

N-(2-((hydroxy(2-((3-((E)-2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)phenyl)methyl)amino)ethyl)-2-((3-((E)-2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide
CAT No: VS-A103038
CAS No: N/A
Mol.F.: C44H36N8O2S2
Mol.Wt.: 772.9
Status: Custom Synthesis

Axitinib Impurity 9

2,2'-Disulfanediylbis(N-methylbenzamide)
CAT No: VS-A103039
CAS No: 2527-58-4
Mol.F.: C16H16N2O2S2
Mol.Wt.: 332.4
Status: Custom Synthesis

Axitinib Impurity A

3,6-diiodo-1H-indazole
CAT No: VS-A103013
CAS No: 319472-78-1
Mol.F.: C7H4I2N2
Mol.Wt.: 369.9
Status: Custom Synthesis

Axitinib Impurity B

2-((1H-indazol-6-yl)thio)-N-methylbenzamide
CAT No: VS-A103014
CAS No: 944835-85-2
Mol.F.: C15H13N3OS
Mol.Wt.: 283.4
Status: Custom Synthesis

Axitinib Impurity C

2-((1H-indazol-6-yl)sulfinyl)-N-methylbenzamide
CAT No: VS-A103015
CAS No: 1959572-97-4
Mol.F.: C15H13N3O2S
Mol.Wt.: 299.4
Status: Custom Synthesis

Axitinib Impurity D

2-((1-acetyl-1H-indazol-6-yl)sulfinyl)-N-methylbenzamide
CAT No: VS-A103016
CAS No: 1959572-98-5
Mol.F.: C17H15N3O3S
Mol.Wt.: 341.4
Status: Custom Synthesis

Axitinib Impurity F

N-methyl-2-((3-(2-(pyridin-2-yl)ethyl)-1H-indazol-6-yl)thio)benzamide
CAT No: VS-A103017
CAS No: 1443118-73-7
Mol.F.: C22H20N4OS
Mol.Wt.: 388.5
Status: Custom Synthesis

Axitinib Impurity H

(E)-2-((1-acetyl-3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)-N-methylbenzamide
CAT No: VS-A103018
CAS No: 1639137-80-6
Mol.F.: C24H20N4O2S
Mol.Wt.: 428.5
Status: Custom Synthesis

Axitinib N-Formyl Impurity

N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-formyl-indazol-6-yl]sulfanyl]-benzamide
CAT No: VS-A103004
CAS No: N/A
Mol.F.: C23H18N4O2S
Mol.Wt.: ?414.5
Status: Custom Synthesis

Axitinib N-Formyl Impurity

(E)-2-((1-formyl-3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)-N-methylbenzamide
CAT No: VS-A103021
CAS No: N/A
Mol.F.: C23H18N4O2S
Mol.Wt.: 414.5
Status: Custom Synthesis

Axitinib N-Hydroxymethyl Impurity

N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-hydroxymethyl-indazol-6-yl]sulfanyl]-benzamide
CAT No: VS-A103005
CAS No: N/A
Mol.F.: C23H20N4O2S
Mol.Wt.: 416.5
Status: Custom Synthesis

Axitinib N-Hydroxymethyl Impurity

(E)-2-((1-(hydroxymethyl)-3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)-N-methylbenzamide
CAT No: VS-A103022
CAS No: N/A
Mol.F.: C23H20N4O2S
Mol.Wt.: 416.5
Status: Custom Synthesis

Axitinib N-Methyl Impurity

N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-methyl-indazol-6-yl]sulfanyl]-benzamide
CAT No: VS-A103008
CAS No: N/A
Mol.F.: C23H20N4OS
Mol.Wt.: 400.5
Status: Custom Synthesis

Axitinib N-Oxide

N-methyl-2-[3-[(1E)-2-(1-oxidopyridinyl) ethenyl]-1H-indazol-6-yl-thio]-benzamide
CAT No: VS-A103011
CAS No: N/A
Mol.F.: C22H18N4O2S
Mol.Wt.: 402.5
Status: Custom Synthesis

Axitinib N-Oxide (E Isomer)

(E)-2-(2-(6-((2-(methylcarbamoyl)phenyl)thio)-1H-indazol-3-yl)vinyl)pyridine 1-oxide
CAT No: VS-A103012
CAS No: N/A
Mol.F.: C22H18N4O2S
Mol.Wt.: 402.5
Status: Custom Synthesis

Axitinib Sulfone

N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]sulfonyl]-benzamide?
CAT No: VS-A103006
CAS No: 1348536-59-3
Mol.F.: C22H18N4O3S
Mol.Wt.: 418.5
Status: Custom Synthesis

Axitinib Sulfoxide

N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]sulfinyl]-benzamide?
CAT No: VS-A103007
CAS No: 1347304-18-0
Mol.F.: C22H18N4O2S
Mol.Wt.: 402.5
Status: Custom Synthesis

Axitinib Thio Benzamide Impurity

(E)-N-methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl)thio)benzamide
CAT No: VS-A103025
CAS No: 885126-35-2
Mol.F.: C27H26N4O2S
Mol.Wt.: 470.6
Status: Custom Synthesis

Calcium

Alcaplant; Aquacal;
CAT No: VS-A103051
CAS No: 7440-70-2
Mol.F.: Ca
Mol.Wt.: 40.08
Status: Custom Synthesis

Cis-axitinib

N-methyl-2-[3-[(1Z)-2-(pyridinyl) ethenyl]-1H-indazol-6-yl-thio]-benzamide
CAT No: VS-A103001
CAS No: 885126-40-9
Mol.F.: C22H18N4OS
Mol.Wt.: 386.5
Status: Custom Synthesis

2-Mercapto-N-methyl-benzamide

2-mercapto-N-methylbenzamide
CAT No: VS-A103020
CAS No: 20054-45-9
Mol.F.: C8H9NOS
Mol.Wt.: 167.2
Status: Custom Synthesis

2-Methyl-5-nitroaniline

2-Methyl-5-Nitroaniline
CAT No: VS-A103023
CAS No: 99-55-8
Mol.F.: C7H8N2O2
Mol.Wt.: 152.2
Status: Custom Synthesis

N-Nitroso Axitinib

(E)-N-methyl-2-((1-nitroso-3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide
CAT No: VS-A103046
CAS No: N/A
Mol.F.: C22H17N5O2S
Mol.Wt.: 415.5
Status: Custom Synthesis

6-Nitroindazole

6-Nitro-1H-Indazole
CAT No: VS-A103024
CAS No: 7597-18-4
Mol.F.: C7H5N3O2
Mol.Wt.: 163.1
Status: Custom Synthesis

Talc

Hydrous Magnesium Silicate
CAT No: VS-A103049
CAS No: 14807-96-6
Mol.F.: H2Mg3O12Si4
Mol.Wt.: 379.27
Status: Custom Synthesis

Categories

Filter by Status